• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    TMT Quantitative Proteomics

      TMT quantitative proteomics is a highly efficient protein quantification technique widely utilized in biological and medical research. By precisely quantifying protein abundance across samples, it reveals molecular changes within complex biological systems. This approach employs chemical labeling reagents to tag peptides from different samples with distinct isobaric mass tags, enabling simultaneous identification and quantification via mass spectrometry (MS). Compared to conventional protein quantification methods such as Western Blot or ELISA, TMT quantitative proteomics offers distinct advantages. It allows simultaneous analysis across multiple experimental groups, enhancing data richness and experimental throughput. Additionally, TMT technology achieves higher quantification sensitivity and precision, enabling the detection of low-abundance proteins. Furthermore, this approach supports large-scale protein profiling, extending beyond targeted protein analysis to capture comprehensive proteomic expression patterns across cellular or tissue samples. With advancements in mass spectrometry technology, TMT quantitative proteomics has emerged as a vital tool for exploring proteomic landscapes across diverse biological and clinical contexts, advancing our understanding of disease mechanisms and informing precision medicine strategies.

       

      The methodological workflow of TMT quantitative proteomics comprises several critical steps: protein extraction, enzymatic digestion, TMT tag labeling, mass spectrometry analysis, and bioinformatics interpretation. Initially, total proteins are extracted from biological samples and enzymatically digested into peptide fragments. These peptides are then labeled with TMT reagents, where each reagent imparts a distinct isobaric mass tag to peptides from different experimental groups. These labeled peptides are subsequently analyzed using high-resolution mass spectrometry, which generates mass spectra to identify peptides and determine their relative abundance. Finally, bioinformatics tools process the acquired data, enabling quantitative comparison of protein expression profiles across experimental groups and revealing functional insights into proteomic alterations under specific biological or pathological conditions.

       

      Successful implementation of TMT quantitative proteomics relies on several critical considerations. First, protein extraction must ensure high purity and integrity, as contaminants or degradation can compromise downstream analysis. Second, precise control over TMT labeling conditions is essential, as deviations in reagent concentration or reaction time can introduce quantification errors. Additionally, robust bioinformatics tools are required for mass spectrometry data interpretation, emphasizing data quality control, normalization, and statistical validation. Experimental design must also carefully balance sample groups to ensure result accuracy, reproducibility, and meaningful biological interpretations.

       

      MtoZ Biolabs provides comprehensive TMT quantitative proteomics services, spanning sample preparation, experimental design, mass spectrometry analysis, and data interpretation. Equipped with state-of-the-art mass spectrometry platforms and a team of experienced professionals, MtoZ Biolabs delivers reliable and high-resolution protein quantification insights, empowering advancements in precision medicine, disease mechanism research, and beyond.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png